Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Free Cash Flow (2016 - 2025)

Jaguar Health (JAGX) has disclosed Free Cash Flow for 11 consecutive years, with -$4.7 million as the latest value for Q3 2025.

  • On a quarterly basis, Free Cash Flow rose 26.05% to -$4.7 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$26.0 million, a 10.29% increase, with the full-year FY2024 number at -$29.4 million, up 11.56% from a year prior.
  • Free Cash Flow was -$4.7 million for Q3 2025 at Jaguar Health, up from -$6.2 million in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of -$4.7 million in Q3 2025 to a low of -$10.5 million in Q2 2022.
  • A 5-year average of -$7.8 million and a median of -$7.5 million in 2023 define the central range for Free Cash Flow.
  • Peak YoY movement for Free Cash Flow: plummeted 223.12% in 2021, then increased 29.14% in 2024.
  • Jaguar Health's Free Cash Flow stood at -$8.9 million in 2021, then rose by 28.02% to -$6.4 million in 2022, then decreased by 16.0% to -$7.5 million in 2023, then fell by 5.03% to -$7.8 million in 2024, then surged by 40.08% to -$4.7 million in 2025.
  • Per Business Quant, the three most recent readings for JAGX's Free Cash Flow are -$4.7 million (Q3 2025), -$6.2 million (Q2 2025), and -$7.3 million (Q1 2025).